Mezigdomide Regimen Promising for Relapsed/Refractory Myeloma

Mezigdomide plus Velcade and dexamethasone or Kyprolis and dexamethasone showed promising response rates across multiple doses in patients with relapsed or refractory multiple myeloma, research showed.

Related Keywords

Spain ,Badalona ,Comunidad Autonoma De Cataluna ,Germany ,Germans ,Albert Oriol ,Triasi Pujol ,Myeloma Research Foundation ,Josep Carreras Institute ,International Staging System ,Multiple Myeloma Research Foundation ,Clinical Research Unit ,Catalan Institute ,Hospital Germans Trias ,Myeloma ,